文献速递老年精神睡眠障碍心境障碍

炎症暴露与老年失眠者的抑郁:一项随机临床试验

Inflammatory Exposure and Depression in Older Adults With Insomnia: A Randomized Clinical Trial.
PubMed 文献 · JAMA Psychiatry · 2025-01-01

该评估者盲法平行随机临床试验纳入160名60岁以上无抑郁成人(53名失眠障碍,107名对照),随机接受内毒素或安慰剂。内毒素诱导的抑郁情绪和症状在失眠组显著大于对照组,且炎症因子升高两组相似。提示老年失眠者对炎症暴露的抑郁易感性增加,应加强监测。

要点

  • 老年失眠障碍者在内毒素诱导炎症后抑郁情绪和症状增加显著大于无失眠者。
  • 内毒素引起的炎症因子升高在失眠组和对照组相似,但仅失眠组炎症反应与抑郁情绪相关。
  • 老年失眠者在炎症暴露期间应警惕抑郁监测,需针对失眠和炎症表型的预防策略。

核心结论

  • 老年失眠障碍者在内毒素诱导炎症暴露后抑郁情绪和症状的增幅显著大于无失眠对照组。

研究设计与样本

  • 社区样本160名60岁以上无抑郁成人,53名失眠障碍者和107名无失眠对照,按失眠状态分层随机接受内毒素或安慰剂。
  • 所有随机参与者均完成方案。

主要发现

  • 内毒素相比安慰剂诱导的POMS-D抑郁情绪增加在失眠组显著大于对照组(条件×组交互,F10,1478=4.7;P<.001)。
  • 观察者评定的POMS-D情绪也显示相似交互效应(F3,450=5.5;P=.001),观察者评定的抑郁症状有临床意义增加。
  • 内毒素诱导的炎症因子升高在两组相似。
  • 炎症反应与POMS-D增加在失眠组相关(β=0.33;95%CI 0.26-0.41;P<.001),对照组无此关联。

临床怎么用

  • 老年失眠障碍者在炎症暴露期间应进行警惕性抑郁监测。
  • 需要针对失眠和炎症表型的选择性抑郁预防策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Insomnia and inflammation are prevalent in older adults, and both are risk factors for late-life depression. Older adults with insomnia who are exposed to inflammatory challenge may be more vulnerable to depression. OBJECTIVE: To determine whether inflammatory exposure induces greater increases in depressive mood and symptoms in older adults with insomnia disorder compared to those without insomnia. DESIGN, SETTING, AND PARTICIPANTS: This assessor-blinded, parallel-condition randomized clinical trial was conducted from August 2017 to November 2022 at a single site in Los Angeles, California, among a community-based sample of 160 nondepressed adults aged 60 years or older (53 with insomnia disorder and 107 without insomnia, or control). Data analysis occurred from July 2023 to August 2024. INTERVENTIONS: Participant groups stratified by insomnia status were randomized to 2 conditions: endotoxin or placebo. MAIN OUTCOMES AND MEASURES: The primary outcome was depressed mood, assessed by the Profiles of Mood States depression subscale (POMS-D). Secondary outcomes were depressive symptom severity and inflammatory cytokines. RESULTS: Among 160 randomized participants eligible for the study (mean [SD] age, 65.9 [4.6] years; 84 female participants [52.5%]), 79 participants (26 with insomnia, 53 control participants) were randomized to endotoxin and 81 (27 with insomnia, 54 control participants) to placebo. All randomized participants completed the protocol. Compared to placebo, endotoxin induced increases in POMS-D to a significantly greater extent in those with insomnia than controls (condition × group interaction, F10,1478 = 4.7; P < .001), with a similar effect for observer-rated POMS-D mood (condition × group interaction, F3,450 = 5.5; P = .001), as well as clinically meaningful increases in observer-rated measures of depressive symptoms. Endotoxin induced similar increases in inflammatory cytokines in both groups. Moderation analyses found that the inflammatory response was associated with increases in POMS-D in the insomnia group (β = 0.33; 95% CI, 0.26-0.41; P < .001) but not in control participants. CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, older adults with insomnia showed an exaggerated vulnerability to depressive mood and symptoms in response to inflammatory challenge. Older adults with insomnia should undergo vigilant depression monitoring during periods of inflammatory exposure; selective depression prevention strategies that target both insomnia and inflammatory phenotypes are needed. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03256760.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Irwin MR, Boyle CC, Cho JH, et al. Inflammatory Exposure and Depression in Older Adults With Insomnia: A Randomized Clinical Trial. JAMA Psychiatry. 2025. PMID: 40668551. doi:10.1001/jamapsychiatry.2025.1327

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。